STAT Plus: Another former Sun Pharma sales rep claims she was fired for complaining about off-label marketing
A former Sun Pharmaceutical sales employee has a filed a lawsuit claiming retaliation for objecting to alleged off-label marketing practices, the second time in four months that one of the world’s largest generic drug makers has been accused of such a move amid rising scrutiny of its business practices.
In her lawsuit, Sandra Hagenbrock, a former national account director, claimed that company managers flouted internal policies prohibiting off-label marketing. Instead, the drug maker tried to “aggressively solicit opportunities to present off-label information to decision-makers (notably, physicians and health plans) about its drugs.” Among them was the Yonsa treatment for prostate cancer.
Continue to STAT Plus to read the full story…
